Browsing by Author Prat Aparicio, Aleix
Showing results 36 to 55 of 67
< previous
next >
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Sep-2016 | Modeling anti-IL-6 therapy using breast cancer patient-derived xenografts | Morancho, Beatriz; Zacarías Fluck, Mariano; Esgueva, Antonio; Bernardó Morales, Cristina; Di Cosimo, Serena; Prat Aparicio, Aleix; Cortés, Javier; Arribas, Joaquín V. (Vicente); Rubio, Isabel T. |
| 28-Sep-2022 | Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer | Schettini, Francesco; Venturini, Sergio; Giuliano, Mario; Lambertini, Matteo; Pinato, David J.; Onesti, Concetta Elisa; De Placido, Pietro; Harbeck, Nadia; Lüftner, Diana; Denys, Hannelore; Van Dam, Peter; Arpino, Grazia; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne; Bartsch, Rupert; Cortés, Javier; Paris, Ida; Martín, Miguel; De Placido, Sabino; Del Mastro, Lucia; Jerusalem, Guy; Curigliano, Giuseppe; Prat Aparicio, Aleix; Generali, Daniele |
| 30-Nov-2022 | Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53-Mutated Metastatic Colorectal Cancer | Lahoz, Sara; Rodríguez, Adela; Fernández, Laia; Gorría, Teresa; Moreno, Reinaldo; Esposito, Francis; Oliveres, Helena; Albiol, Santiago; Saurí, Tamara; Pesantez, David; Riu Viladoms, Gisela; Cuatrecasas Freixas, Miriam; Jares Gerboles, Pedro; Pedrosa, Leire; Pineda, Estela; Postigo, Antonio; Castells Garangou, Antoni; Prat Aparicio, Aleix; Maurel Santasusana, Joan; Camps, Jordi |
| Nov-2022 | Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer | Cortellini, Alessio; Aguilar Company, Juan; Salazar Soler, Ramón; Bower, Mark; Sita-Lumsden, Ailsa; Plaja, Andrea; Lee, Alvin J. X.; Bertuzzi, Alexia; Tondini, Carlo; Diamantis, Nikolaos; Martínez, Clara; Prat Aparicio, Aleix; Apthorp, Eleanor; Gennari, Alessandra; Pinato, David J. |
| 8-Jun-2020 | Nectin-2 Expression on Malignant Plasma Cells Is Associated With Better Response to TIGIT Blockade in Multiple Myeloma | Lozano Garcia, Ester; Mena Jaramillo, Mari Pau; Díaz Sánchez, Tania; Martin-Antonio, Beatriz; Leon, Sheila; Rodríguez-Lobato, Luis Gerardo; Oliver Caldés, Aina; Cibeira, María Teresa; Bladé, J. (Joan); Prat Aparicio, Aleix; Rosiñol Dachs, Laura; Fernández de Larrea Rodríguez, Carlos José |
| 18-Sep-2019 | Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial | Adamo, Barbara; Bellet Ezquerra, Meritxell; Paré, Laia; Pascual, Tomás; Vidal Losada, Maria Jesús; Pérez Fidalgo, José A.; Blanch, Salvador; Martínez, Noelia; Murillo, Laura; Gómez Pardo, Patricia; López González, Ana; Amillano, Kepa; Canes, Jordi; Galván, Patricia; González Farré, Blanca; Gonzalez, Xavier; Villagrasa, Patricia; Ciruelos, Eva; Prat Aparicio, Aleix |
| 4-Oct-2012 | PAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers | Bastien, Roy R.L.; Rodríguez-Lescure, Álvaro; Ebbert, Mark T.W.; Prat Aparicio, Aleix; Munárriz, Blanca; Rowe, Leslie; Miller, Patricia; Ruiz-Borrego, Manuel; Anderson, Daniel; Lyons, Bradley; Álvarez, Isabel; Dowell, Tracy; Wall, David; Seguí, Miquel A.; Barley, Lee; Boucher, Kenneth M.; Alba, Emilio; Pappas, Lisa; Davis, Carole A.; Aranda, Ignacio; Fauron, Christiane; Stijleman, Inge J.; Palacios, José; Antón, Antonio; Carrasco, Eva; Caballero, Rosalía; Ellis, Matthew J.; Nielsen, Torsten O.; Perou, Charles M.; Astill, Mark; Bernard, Philip S.; Martín, Miguel |
| 25-Sep-2019 | PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution | Pernas, Sònia; Petit, Anna; Climent, Fina; Paré, Laia; Perez Martin, J.; Ventura, Luz; Bergamino Sirvén, Milana; Galván, Patricia; Falo, Catalina; Morilla, Idoia; Fernandez Ortega, Adela; Stradella, Stradella; Rey, Montse; Garcia Tejedor, Amparo; Gil Gil, Miguel; Prat Aparicio, Aleix |
| 31-Jan-2023 | Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer | Tagliamento, Marco; Gennari, Alessandra; Lambertini, Matteo; Salazar Soler, Ramón; Harbeck, Nadia; Mastro, Lucia del; Aguilar Company, Juan; Bower, Mark; Sharkey, Rachel; Pria, Alessia dalla; Plaja, Andrea; Jackson, Amanda; Handford, Jasmine; Sita-Lumsden, Ailsa; Martínez Vila, Clara; Matas, Marta; Miguel Rodríguez, Ana; Vincenzi, Bruno; Tonini, Giuseppe; Bertuzzi, Alexia; Brunet, Joan; Pedrazzoli, Paolo; Avanzo, Francesca d'; Biello, Federica; Sinclair, Alasdair; Lee, Alvin J.X.; Rossi, Sabrina; Rizzo, Gianpiero; Mirallas, Oriol; Pimentel, Isabel; Iglesias, María; Sanchez de Torre, Ana; Guida, Annalisa; Berardi, Rossana; Zambelli, Alberto; Tondini, Carlo; Filetti, Marco; Mazzoni, Francesca; Mukherjee, Uma; Diamantis, Nikolaos; Parisi, Alessandro; Aujayeb, Avinash; Prat Aparicio, Aleix; Libertini, Michela; Grisanti, Salvatore; Rossi, Maura; Zoratto, Federica; Generali, Daniele; Saura, Cristina; Lyman, Gary H.; Kuderer, Nicole M.; Pinato, David J.; Cortellini, Alessio |
| 20-Jan-2020 | Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade | Brasó Maristany, Fara; Griguolo, Gaia; Pascual, Tomás; Paré, Laia; Nuciforo, Paolo; Llombart Cussac, Antonio; Bermejo de las Heras, Begoña; Oliveira, Mafalda; Morales, Serafín; Martínez, Noelia; Vidal Losada, Maria Jesús; Adamo, Barbara; Martínez, Olga; Pernas, Sònia; López, Rafael; Muñoz Mateu, Montserrat; Chic Ruché, Núria; Galván, Patricia; Garau, Isabel; Manso, Luis; Alarcón, Jesús; Martínez, Eduardo; Gregorio, Sara; Gomis, Roger R.; Villagrasa, Patricia; Cortés, Javier; Ciruelos, Eva; Prat Aparicio, Aleix |
| 1-Dec-2011 | Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases | Adamo, Barbara; Deal, Allison M.; Burrows, Emily; Geradts, Joseph; Hamilton, Erika; Blackwell, Kimberly L,; Livasy, Chad; Fritchie, Karen; Prat Aparicio, Aleix; Harrell, J. Chuck; Ewend, Matthew G.; Carey, Lisa A.; Miller, C. Ryan; Anders, Careu K. |
| 30-Apr-2014 | Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling | Cuenca López, María D.; Montero, Juan Carlos; Morales, Jorge C.; Prat Aparicio, Aleix; Pandiella, Atanasio; Ocana, Alberto |
| 7-Aug-2014 | Predicting response and survival in chemotherapy-treated triple-negative breast cancer | Prat Aparicio, Aleix; Lluch Hernández, Ana; Albanell Mestres, Joan; Barry, W.T.; Fan, Cheng; Chacón, José Ignacio; Parker, Joel S.; Calvo, L.; Plazaola, A.; Arcusa, Angels; Seguí, Miquel A.; Burgues, O.; Ribelles, N.; Rodríguez-Lescure, Álvaro; Guerrero, A.; Ruiz-Borrego, Manuel; Munárriz, Blanca; López, J.A.; Adamo, Barbara; Cheang, Maggie C. U.; Li Y.; Hu, Z.; Gulley, M.L.; Vidal, Maria José; Pitcher, B.N.; Liu, M.C.; Citron, M.L.; Ellis, Matthew J.; Mardis, Elaine R.; Vickery, T.; Hudis, C.A.; Winer, E.P.; Carey, Lisa A.; Caballero, Rosalía; Carrasco, Eva; Martín, M.; Perou, Charles M.; Alba, Emilio |
| Feb-2024 | Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry. | Mostaghim, Anahita; Minkove, Samuel; Aguilar Company, Juan; Ruiz, Isabel (Ruiz Camps); Eremiev-Eremiev, Simeon; Dettorre, Gino M.; Fox, Laura; Tondini, Carlo; Brunet, Joan; Carmona-García, M. Carmen; Lambertini, Matteo; Bower, Mark; Newsom-Davis, Thomas; Sharkey, Rachel; Pria, Alessia dalla; Rossi, Maura; Plaja, Andrea; Salazar Soler, Ramón; Sureda, Anna; Prat Aparicio, Aleix; Michalarea, Vasiliki; Hemelrijck, Mieke Van; Sita Lumsden, Ailsa; Bertuzzi, Alexia; Rimassa, Lorenza; Rossi, Sabrina; Rizzo, Gianpiero; Pedrazzoli, Paolo; Lee, Alvin J. X.; Murphy, Cian; Belessiotis, Katherine; Diamantis, Nikolaos; Mukherjee, Uma; Pommeret, Fanny; Stoclin, Annabelle; Martinez-Vila, Clara; Bruna, Riccardo; Gaidano, Gianluca; D’Avanzo, Francesca; Gennari, Alessandra; Athale, Janhavi; Eichacker, Peter; Pinato, David J.; Torabi-Parizi, Parizad; Cortellini, Alessio; OnCovid study group |
| 10-Jun-2011 | Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole and Exemestane for Postmenopausal Women With Estrogen Receptor-Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype -ACOSOG Z1031 | Ellis, Matthew J.; Suman, Vera J.; Hoog, Jeremy; Lin, Li; Snider, Jacqueline; Prat Aparicio, Aleix; Parker, Joel S.; Luo, Jingqin; DeSchryver, Katherine; Allred, D.Craig; Esserman, Laura J.; Unzeitig, Gary W.; Margenthaler, Julie; Babiera, Gildy V.; Marcom, P. Kelly; Guenther, Joseph M.; Watson, Mark A.; Leitch, Marylin; Hunt, Kelly; Olson, John A. |
| 30-Mar-2021 | RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer | Sanz Moreno, Adrián; Palomeras, Sonia; Pedersen, Kim; Morancho, Beatriz; Pascual, Tomás; Galván, Patricia; Benítez, Sandra; Gómez Miragaya, Jorge; Ciscar, Marina; Jimenez, Maria; Pernas, Sònia; Petit, Anna; Soler, María Teresa; Viñas, Gemma; Alsaleem, Mansour; Rakha, Emad A.; Green, Andrew R.; Santamaria, Patricia G.; Mulder, Celine; Lemeer, Simone; Arribas, Joaquín V. (Vicente); Prat Aparicio, Aleix; Puig, Teresa; González Suárez, Eva |
| May-2017 | Resistance to taxanes in triple negative breast cancer associates with the dynamics of a CD49f+ tumor initiating population | Gómez Miragaya, Jorge; Palafox Sánchez, Marta; Paré, Laia; Yoldi, Guillermo; Ferrer, Irene; Vila, Sergi; Galván, Patricia; Pellegrini, Pasquale; Pérez-Montoyo, Hector; Igea, Ana; Muñoz Moruno, Purificación; Esteller, Manel; Nebreda, Àngel R.; Urruticoechea Ribate, Ander; Morilla, Idoia; Pernas, Sònia; Climent, Fina; Soler, María Teresa; Petit, Anna; Serra Elizalde, Violeta; Prat Aparicio, Aleix; González Suárez, Eva |
| 18-Dec-2015 | Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. | Prat Aparicio, Aleix; Fan, Cheng; Fernández Martínez, Aranzazu; Hoadley, Katherine A.; Martinello, Rossella; Vidal Losada, Maria Jesús; Viladot, Margarita; Pineda, Estela; Arance, Ana; Muñoz Mateu, Montserrat; Paré, Laia; Cheang, Maggie C. U.; Adamo, Barbara; Perou, Charles M. |
| 9-Jan-2019 | Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial | Gavilá, Joaquín; Oliveira, Mafalda; Pascual, Tomás; Perez-Garcia, Jose; Gonzàlez, Xavier; Canes, Jordi; Paré, Laia; Calvo Serrano, Isabel; Ciruelos, Eva; Muñoz Mateu, Montserrat; Virizuela, Juan A.; Ruiz, Isabel; Andrés, Raquel; Perelló, Antonia; Martínez, Jerónimo; Morales, Serafín; Marín Aguilera, Mercedes; Martínez, Debora; Quero, Juan C.; Llombart-Cussac, Antonio; Prat Aparicio, Aleix |
| 7-Jun-2019 | Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain Metastasis | Pascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic Ruché, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix |